Novo Nordisk introduces new insulin pen

PRINCETON, N.J. Danish drug maker Novo Nordisk announced Monday that it had redesigned a pre-filled insulin pen to allow diabetes patients to use less force when pushing the button to inject their insulin.

The FlexPen, the top-selling pre-filled insulin pen, is available with Levemir (insulin demetir [rDNA origin]), NovoLog (insulin aspart [rDNA origin]) and NovoLog Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection [rDNA origin]).

The updated FlexPen has enhanced color branding, with color-identified cartridge holders for both the Levemir and NovoLog versions.

“Although insulin pens are underused in the U.S. versus other countries, the continued innovation we’ve seen with FlexPen may help meet the needs of people living with the challenges of this disease,” Bruce Bode of Atlanta Diabetes Associates said in a statement.

Login or Register to post a comment.